Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

193 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 41.7M shares of 58.9M outstanding shares and own 70.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.89M shares), STATE STREET CORP (3.69M shares), RENAISSANCE TECHNOLOGIES LLC (3.3M shares), DIMENSIONAL FUND ADVISORS LP (2.73M shares), Epoch Investment Partners, Inc. (2.72M shares), Palo Alto Investors LP (2.17M shares), GOLDMAN SACHS GROUP INC (1.7M shares), Assenagon Asset Management S.A. (1.59M shares), Nuveen Asset Management, LLC (1.08M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.03M shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.